Home
About Us
Introduction
R&D and Production
Platform
Social Responsibility
Products
GLP-1 Side Chains
AEEA
AEEA-AEEA
Boc-AEEA-OH
Fmoc-AEEA-OH
tBuO-C20-Glu-OtBu
tBuO-C20-Glu(OSu)-OtBu
Peptide Intermediates
Fmoc-His-Aib-OH
Fmoc-Ile-Aib-OH
Fmoc-Tyr(tBu)-Aib-OH
Fmoc-Glu(OtBu)-Aib-OH
Fmoc-His(Fmoc)-Aib-OH
Fmoc-His(Fmoc)-Aib-OSu
Tirzepatide Fragments
CAS:2682040-93-1
CAS:3034670-52-2
CAS:2656383-23-0
CAS:2461524-68-3
CAS:2656383-24-1
CAS:2656383-25-2
API & Excipients
Tirzepatide
Semaglutide
Salcaprozate Sodium (SNAC）
Cosmetic Peptides
Oligopeptide-1
NonaPeptide-1
Copper Tripeptide-1
Acetyl Hexapeptide-8
Palmitoyl Tripeptide-1
Decarboxy Carnosine HCl
Active Ingredients
Bisyne<sup>®</sup>
CG HPR
CG Chroman'6<sup>®</sup>
CG Retinol
CG HP100
Adsolue <sup>®</sup> TPGS
News
Events
Industry News
Contact
Search
marketing@congenpharm.com
EGF is borderline, while oligopeptide-1 is the right way.
2024-02-22
Great start! Congen Pharma obtains the authorization of a Chinese invention patent for "Blue Copper Peptide"
Scientific Research and Innovation | Congen Pharma Awarded Boseine China Invention Patent
2024-02-06
Congen Pharma obtained a Chinese invention patent for dihydro-oat alkaloid, continuing to increase investment in scientific research and innovation.
Good News | The "Huaju Cup" Guangdong Eastern and Northern Innovation and Entrepreneurship Competition Concludes, Congen Wins Excellence Award
2024-01-25
